Table 3. Maximum doping substance intake and doping control risk

Supplement	Weight maximum daily dose	Compound (class)	Contamination calculation	Positive doping control threshold	Estimated potential risk
B5	1.5 g	higenamine	1.5 μg	10 μg	NO 2017
F1	15 g	BMPEA † NBDMPEA † Oxilofrine †	0.39 g 15 mg 0.17 g	50 μg 50 μg 50 μg	YES YES YES
F3	20 g	BMPEA † NBDMPEA † Oxilofrine †	0.98 g 0.48 g 0.80 g	50 μg 50 μg 50 μg	YES YES YES
G2	3.0 g	Endogenous AAS (1) higenamine oxilofrine testosterone	3.0 μg 3.0 μg 3.0 μg 3.0 μg	1 mg 10 μg 50 μg 1 mg	NO NO 2017 NO NO
G3	3.0 g	cathine ephedrine methylephedrine oxilofrine † strychnine testosterone	3.0 μg 3.0 μg 3.0 μg 0.17 g 3.0 μg 3.0 μg	5 mg 10 mg 10 mg 50 μg 50 μg 1 mg	NO NO NO YES NO NO
H23	4.8 g	Endogenous AAS (6) ephedrine higenamine	29 μg 4.8 μg 4.8 μg	1 mg 10 mg 50 μg	NO NO NO 2017
O2	4.8 g	higenamine	4.8 μg	10 μg	NO 2017
Q1	89 g	DMBA oxilofrine	89 μg 89 μg	50 μg 50 μg	YES YES

†= high level finding, 2017 = before September 2017 this product was estimated to potentially cause a positive doping test, 3=this product contained 3 components which were tested separately